Kevin Fischbeck
Stock Analyst at B of A Securities
(4.10)
# 498
Out of 4,667 analysts
160
Total ratings
65.71%
Success rate
7.85%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Upgrades: Neutral | $247 → $308 | $293.97 | +4.77% | 14 | Nov 6, 2024 | |
| ARDT Ardent Health Partners | Downgrades: Neutral | $22 → $19 | $16.44 | +15.57% | 2 | Nov 6, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $675 → $650 | $600.50 | +8.24% | 21 | Oct 16, 2024 | |
| AMN AMN Healthcare Services | Downgrades: Underperform | $65 → $48 | $24.80 | +93.55% | 4 | Oct 7, 2024 | |
| AGL agilon health | Downgrades: Underperform | $3 | $1.67 | +79.64% | 2 | Oct 2, 2024 | |
| DVA DaVita | Maintains: Underperform | $139 → $145 | $161.40 | -10.16% | 12 | Aug 7, 2024 | |
| ELV Elevance Health | Downgrades: Neutral | $646 → $530 | $397.48 | +33.34% | 3 | Jul 18, 2024 | |
| ACHC Acadia Healthcare Company | Maintains: Buy | $105 → $90 | $39.10 | +130.18% | 5 | May 2, 2024 | |
| MOH Molina Healthcare | Downgrades: Underperform | $439 | $294.64 | +49.00% | 15 | Apr 1, 2024 | |
| AHCO AdaptHealth | Downgrades: Underperform | $6.5 | $9.72 | -33.13% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $11.95 | -39.33% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $79 → $72 | $59.10 | +21.83% | 11 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $323.39 | +8.23% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $183 | $197.52 | -7.35% | 14 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $22.51 | +99.91% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $74 | $98.93 | -25.20% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $294 → $323 | $333.00 | -3.00% | 8 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.83 | +43.60% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $38.09 | -8.11% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $3.35 | +198.51% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 → $50 | $151.84 | -67.07% | 4 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $10.21 | -26.54% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $21.88 | -17.73% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $14.49 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $51.60 | -63.18% | 2 | Feb 9, 2018 |
Humana
Nov 6, 2024
Upgrades: Neutral
Price Target: $247 → $308
Current: $293.97
Upside: +4.77%
Ardent Health Partners
Nov 6, 2024
Downgrades: Neutral
Price Target: $22 → $19
Current: $16.44
Upside: +15.57%
UnitedHealth Group
Oct 16, 2024
Maintains: Buy
Price Target: $675 → $650
Current: $600.50
Upside: +8.24%
AMN Healthcare Services
Oct 7, 2024
Downgrades: Underperform
Price Target: $65 → $48
Current: $24.80
Upside: +93.55%
agilon health
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $1.67
Upside: +79.64%
DaVita
Aug 7, 2024
Maintains: Underperform
Price Target: $139 → $145
Current: $161.40
Upside: -10.16%
Elevance Health
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $397.48
Upside: +33.34%
Acadia Healthcare Company
May 2, 2024
Maintains: Buy
Price Target: $105 → $90
Current: $39.10
Upside: +130.18%
Molina Healthcare
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $294.64
Upside: +49.00%
AdaptHealth
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $9.72
Upside: -33.13%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $11.95
Upside: -39.33%
Sep 5, 2023
Upgrades: Neutral
Price Target: $79 → $72
Current: $59.10
Upside: +21.83%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $323.39
Upside: +8.23%
Jul 27, 2023
Maintains: Buy
Price Target: $183
Current: $197.52
Upside: -7.35%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $22.51
Upside: +99.91%
Apr 28, 2023
Maintains: Buy
Price Target: $69 → $74
Current: $98.93
Upside: -25.20%
Apr 24, 2023
Maintains: Buy
Price Target: $294 → $323
Current: $333.00
Upside: -3.00%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.83
Upside: +43.60%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $38.09
Upside: -8.11%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $3.35
Upside: +198.51%
Jan 5, 2021
Upgrades: Buy
Price Target: $45 → $50
Current: $151.84
Upside: -67.07%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $10.21
Upside: -26.54%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $21.88
Upside: -17.73%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $14.49
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $51.60
Upside: -63.18%